#oncology — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #oncology, aggregated by home.social.
-
https://www.europesays.com/ie/706849/ UCLA researchers present new radiation advances at ASTRO 2026 #Bile #cancer #chemotherapy #ClinicalTrial #Éire #Genetic #genomics #HeadAndNeckCancer #Health #Hormone #IE #Ireland #Liver #LiverTransplantation #medicine #Neck #oncology #Preclinical #Prostate #ProstateCancer #RadiationTherapy #Research #Therapeutics #therapy #Tumor
-
GSK Adds Another Cancer Drug in a $750 Million Deal. Is its Oncology Bet Getting Bigger?
GSK plc (NYSE:GSK) is adding another cancer drug to a pipeline that has been getting considerably more attention…
#EuropeSays #Britain #Europe #EU #GSK #cancerdrug #ChimagenBiosciences #GSKplc #multiplemyeloma #Oncology #potential
https://www.europesays.com/britain/131362/ -
https://www.europesays.com/britain/131362/ GSK Adds Another Cancer Drug in a $750 Million Deal. Is its Oncology Bet Getting Bigger? #CancerDrug #ChimagenBiosciences #GSK #GSKPlc #MultipleMyeloma #Oncology #potential
-
https://www.europesays.com/ch/136069/ Roche’s Genentech inks $1.5B bispecific pact with fast-rising Earendil #AIAndMachineLearning #biotech #BispecificAntibodies #Deals #FierceBiotechHomepage #Genentech #LicensingDeals #Oncology #Roche
-
AstraZeneca (AZN): Can Precision Medicine Offset a Narrower Breast Cancer Market?
AstraZeneca PLC (NYSE:AZN) announced on September 11, 2026, that its Phase III SERENA-4 trial evaluating Etcamah (camizestrant) in…
#EuropeSays #Britain #Europe #EU #AstraZeneca #advancedbreastcancer #AstraZenecaPLC #breAstcancer #clinicaltrial #commercialexpansion #Oncology #primaryendpoint
https://www.europesays.com/britain/131225/ -
https://www.europesays.com/britain/131225/ AstraZeneca (AZN): Can Precision Medicine Offset a Narrower Breast Cancer Market? #AdvancedBreastCancer #AstraZeneca #AstraZenecaPLC #BreAstCancer #ClinicalTrial #CommercialExpansion #Oncology #PrimaryEndpoint